Colony Capital Inc (CLNY) Fundamental Analysis & Valuation

NYSE:CLNY

Current stock price

8.5
+0.52 (+6.52%)
At close:
8.18
-0.32 (-3.76%)
After Hours:

This CLNY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CLNY Profitability Analysis

1.1 Basic Checks

  • CLNY had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -15.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -140.48%
PM (TTM) -193.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CLNY Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for CLNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • A Debt/Equity ratio of 1.08 is on the high side and indicates that CLNY has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CLNY Growth Analysis

3.1 Past

  • CLNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.39%, which is quite impressive.
  • Looking at the last year, CLNY shows a very negative growth in Revenue. The Revenue has decreased by -41.59% in the last year.
  • CLNY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.25% yearly.
EPS 1Y (TTM)37.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)-41.59%
Revenue growth 3Y-21.43%
Revenue growth 5Y9.25%
Sales Q2Q%-37.79%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.61% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.23% on average over the next years.
EPS Next Y21.74%
EPS Next 2Y37.1%
EPS Next 3Y23.9%
EPS Next 5Y14.61%
Revenue Next Year-20.16%
Revenue Next 2Y-9.7%
Revenue Next 3Y-1.73%
Revenue Next 5Y2.23%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLNY Yearly Revenue VS EstimatesCLNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CLNY Yearly EPS VS EstimatesCLNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. CLNY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLNY. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLNY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLNY Price Earnings VS Forward Price EarningsCLNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -14.69
CLNY Per share dataCLNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • CLNY's earnings are expected to grow with 23.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.1%
EPS Next 3Y23.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. CLNY Dividend Analysis

5.1 Amount

  • CLNY has a Yearly Dividend Yield of 1.29%. Purely for dividend investing, there may be better candidates out there.
  • Compared to the average S&P500 Dividend Yield of 1.80, CLNY is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

  • The dividend of CLNY decreases each year by -22.76%.
  • CLNY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-22.76%
Div Incr YearsN/A
Div Non Decr YearsN/A
CLNY Yearly Dividends per shareCLNY Yearly Dividends per shareYearly Dividends per share 2016 2018 2019 2020 0.5 1 1.5

5.3 Sustainability

  • CLNY has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-4.92%
EPS Next 2Y37.1%
EPS Next 3Y23.9%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLNY Fundamentals: All Metrics, Ratios and Statistics

Colony Capital Inc

NYSE:CLNY (6/21/2021, 8:04:00 PM)

After market: 8.18 -0.32 (-3.76%)

8.5

+0.52 (+6.52%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners1.22%
Ins Owner Change0%
Market Cap4.14B
Revenue(TTM)1.34B
Net Income(TTM)-2.58B
Analysts100
Price Target8.61 (1.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend0.11
Dividend Growth(5Y)-22.76%
DP-4.92%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB N/A
EV/EBITDA -14.69
EPS(TTM)-1.39
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.74
BVpS13.04
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -15.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -140.48%
PM (TTM) -193.24%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y21.74%
EPS Next 2Y37.1%
EPS Next 3Y23.9%
EPS Next 5Y14.61%
Revenue 1Y (TTM)-41.59%
Revenue growth 3Y-21.43%
Revenue growth 5Y9.25%
Sales Q2Q%-37.79%
Revenue Next Year-20.16%
Revenue Next 2Y-9.7%
Revenue Next 3Y-1.73%
Revenue Next 5Y2.23%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Colony Capital Inc / CLNY Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Colony Capital Inc (CLNY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLNY.


What is the valuation status of Colony Capital Inc (CLNY) stock?

ChartMill assigns a valuation rating of 3 / 10 to Colony Capital Inc (CLNY). This can be considered as Overvalued.


Can you provide the profitability details for Colony Capital Inc?

Colony Capital Inc (CLNY) has a profitability rating of 1 / 10.


What is the financial health of Colony Capital Inc (CLNY) stock?

The financial health rating of Colony Capital Inc (CLNY) is 1 / 10.